Synthesis and studies on antidepressant activity of 2′,4′,6′-trihydroxychalcone derivatives

[1]  Jian-Mei Li,et al.  Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin. , 2008, Life sciences.

[2]  M. Samoilov,et al.  Antidepressant-like effects of mild hypoxia preconditioning in the learned helplessness model in rats , 2007, Neuroscience Letters.

[3]  G. Hong,et al.  Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors. , 2007, Bioorganic & medicinal chemistry.

[4]  Y. Prasad,et al.  Synthesis and Antidepressant Activity of Some 1,3,5-Triphenyl-2-pyrazolines and 3-(2′′-Hydroxynaphthalen-1′′-yl)-1,5-diphenyl-2-pyrazolines. , 2006 .

[5]  J. Kawabata,et al.  DPPH Radical Scavenging Reaction of Hydroxy- and Methoxychalcones , 2006, Bioscience, biotechnology, and biochemistry.

[6]  Y. Rajendra Prasad,et al.  Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2''-hydroxy naphthalen-1''-yl)-1,5-diphenyl-2-pyrazolines. , 2005, Bioorganic & medicinal chemistry letters.

[7]  Zhe-shan Quan,et al.  Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. , 2005, Bioorganic & medicinal chemistry letters.

[8]  K. Lee,et al.  Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus Desmos. , 2003, Bioorganic & medicinal chemistry letters.

[9]  T. Nakazawa,et al.  Antidepressant-like effects of apigenin and 2,4,5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. , 2003, Biological & pharmaceutical bulletin.

[10]  Athina Markou,et al.  Assessing antidepressant activity in rodents: recent developments and future needs. , 2002, Trends in pharmacological sciences.

[11]  P. Willner,et al.  The validity of animal models of predisposition to depression. , 2002, Behavioural pharmacology.

[12]  S. Roose.  Treating sexual dysfunction: psychiatry's role in the age of sildenafil. , 2002, The Journal of clinical psychiatry.

[13]  A. Bekhit,et al.  Synthesis and antimicrobial evaluation of chalcone and syndrome derivatives of 4(3H)-quinazolinone. , 2001, Bollettino chimico farmaceutico.

[14]  R. Enriz,et al.  In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. , 2001, Bioorganic & medicinal chemistry.

[15]  A. Nahrstedt,et al.  Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. , 2000, Planta medica.

[16]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[17]  A. Meli,et al.  Does the behavioral “despair” test measure “despair”? , 1986, Physiology & Behavior.

[18]  R. Porsolt,et al.  Behavioral despair in mice: a primary screening test for antidepressants. , 1977, Archives internationales de pharmacodynamie et de therapie.

[19]  W. Cullen,et al.  Research confuses me: what is the difference between case-control and cohort studies in quantitative research? , 2013, Irish medical journal.

[20]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[21]  G. Viana,et al.  Analgesic and antiinflammatory effects of chalcones isolated from Myracrodruon urundeuva allemão. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[22]  A. Rush,et al.  Overview of psychiatric disorders and the role of newer antidepressants. , 2002, The Journal of clinical psychiatry.

[23]  P. Willner.  Animal models as simulations of depression. , 1991, Trends in pharmacological sciences.

[24]  J. Cillard,et al.  Hydroxyl radical scavenging activity of flavonoids , 1987 .

[25]  Mary Ann Moran,et al.  Synthesis and Evaluation , 1986 .

[26]  R. D. Porsalt.  Behavioural despair in mice : A primary screening test for antidepressants , 1977 .